Abstract
The pathogenesis of idiopathic nephrotic syndrome is not completely understood. We postulate that cytokine gene polymorphisms may influence susceptibility or clinical course in Idiopathic Nephrotic Syndrome. Polymorphisms of IL-4, IL-6, and TNF-α cytokines were investigated in 150 children with Idiopathic Nephrotic Syndrome and 569 healthy controls by using polymerase chain reaction and restriction fragment length polymorphism. On comparing patient with controls strong association were found for IL-6, TNF-α and IL-4 at allelic level (IL-6-G174C (G vs. C): P = <0.001; OR = 6.33, TNF-α-G308A (G vs. A): P = <0.001; OR = 1.99, IL-4-C590T (C vs. T): P = 0.048; OR = 1.38). Further when SR group was compared with SS group significant association was found at genotypic level in all the studied genetic polymorphisms. Studied cytokine gene polymorphisms may influence susceptibility to idiopathic nephrotic syndrome and might affect steroid response in INS patients.
Similar content being viewed by others
References
Mathieson PW. Cytokine polymorphisms and nephrotic syndrome. Clin Sci. 2002;102:513–4.
Fodor P, Saitua MT, Rodriguez E, Gonzalez B, Schlesinger L. T-cell dysfunction in minimal-change nephrotic syndrome of childhood. Am J Dis Child. 1982;136:713–7.
Kimata H, Fujimoto M, Furusho K. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol. 1995;25:1497–501.
Neuhaus TJ, Wadhwa M, Callard R, Barratt TM. Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid sensitive nephrotic syndrome. Clin Exp Immunol. 1995;100:475–9.
Yap HK, Cheung W, Murugasu B, et al. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol. 1999;10:529–37.
Punnonen J, Aversa G, Cocks BG, et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci USA. 1993;90:3730–4.
Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE. Upregulation of interleukin-4 and CD23/Fcepsilon RII in minimal change nephrotic syndrome. Pediatr Nephrol. 1999;13:199–204.
Noronha IL, Niemir Z, Stein H, Waldherr R. Cytokines and growth factors in renal disease. Nephrol Dial Transplant. 1995;10:775–86.
Tenbrock K, Schubert A, Stapenhorst L, Kemper MJ, Gellermann J, Timmermann K, Müller-Wiefel DE, Querfeld U, Hoppe B, Michalk D. Type I IgE receptor, interleukin 4 receptor and interleukin 13 polymorphisms in children with nephrotic syndrome. Clin Sci. 2002;102:507–12.
Liu ZH, Cheng ZH, Yu YS, Tang Z, Li LS. Interleukin-1 receptor antagonist allele: Is it a genetic link between Henoch-Schonlein nephritis and IgA nephropathy? Kidney Int. 1997;51:1938–42.
Shu KH, Lee SH, Cheng CH, Wu MJ, Lian JD. Impact of interleukin-1 receptor antagonist and tumor necrosis factor alpha gene polymorphism on IgA nephropathy. Kidney Int. 2000;58:783–9.
Van der Paardt M, Crusius JB, Garcia-Gonzalez MA, Baudoin P, Kostense PJ, Alizadeh BZ, Dijkmans BA, Pena AS, van der Horst-Bruinsma IE. Interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in ankylosing spondylitis. Rheumatology. 2002;41:1419–23.
Mann CL, Davies MB, Stevenson VL, Leary SM, Boggild MD, Ko Ko C, Jones PW, Fryer AA, Strange RC, Thompson AJ, Hawkins CP. Interleukin 1 genotypes in multiple sclerosis and relationship to disease severity. J Neuroimmunol. 2002;129:197–204.
Gulati S, Godbole M, Singh U, Gulati K, Srivastava A. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease? Am J Kidney Dis. 2003;41:1163–9.
Tischendorf JJ, Yagmur E, Scholten D, Vidacek D, Koch A, Winograd R. The interleukin-6 (IL6)-174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet. 2007;34:413–8.
Kobayashi Y, Arakawa H, Suzuki M, Takizawa T, Tokuyama K, Morikawa A. Polymorphisms of interleukin-4-related genes in Japanese children with minimal change nephrotic syndrome. Am J Kidney Dis. 2003;42:271–6.
Wilson AG, di Giovine FS, Blakemore AI, Duff GW. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product. Hum Mol Genet. 1992;1(5):353–6.
Carter DB, Deibel MR Jr, Dunn CJ, Tomich CS, Laborde AL, Slightom JL, Berger AE, Bienkowski MJ, Sun FF, McEwan RN. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature. 1990;344:633–8.
Mosmann TR, Cherwinski H, Bond MW. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol. 1986;136:2348–57.
Liu HM, Shen Q, Xu H, Yang Y. Significance of polymorphisms in variable number of tandem repeat region of interleukin-4 gene in recurrence of childhood steroid sensitive nephrotic syndrome. Zhonghua Er Ke Za Zhi. 2005;43:431–3.
Acharya B, Shirakawa T, Pungky A, Damanik P, Massi MN, Miyata M. Polymorphism of the interleukin-4, interleukin-13, and signal transducer and activator of transcription 6 genes in Indonesian children with minimal change nephrotic syndrome. Am J Nephrol. 2005;25:30–5.
Masutani K, Taniguchi M, Nakashima H, Yotsueda H, Kudoh Y, Tsuruya K. Up-regulated interleukin-4 production by peripheral T-helper cells in idiopathic membranous nephropathy. Nephrol Dial Transplant. 2004;19:580–6.
Mittal RD, Manchanda PK. Association of interleukin (IL)-4 intron-3 and IL-6-174 G/C gene polymorphism with susceptibility to end-stage renal disease. Immunogenetics. 2007;59:159–65.
DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M. Interleukin-6-174G3C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 2003;63:8051–6.
Castellucci L, Menezes E, Oliveira J, Magalhaes A, Guimaraes LH, Lessa M. IL6-174 G/C promoter polymorphism influences susceptibility to mucosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis. 2006;194:519–27.
Schotte H, Schlüter B, Rust S, Assmann G, Domschke W, Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology. 2001;40:393–400.
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;1:3195–9.
Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-α in the nephrotic syndrome in humans. Am J Kidney Dis. 1993;21:251–9.
Bustos C, González E, Muley R, Alonso JL, Egido J. Increase of tumor necrosis factor α synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Investig. 1994;24:799–805.
Matsumoto K. Spontaneous and LPS-stimulated release of tumor necrosis factor-alpha by peripheral blood monocytes in patients with focal glomerular sclerosis. Nephron. 1995;70:118–9.
Acknowledgment
We are indebted to SGPGIMS, Lucknow for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jafar, T., Agrawal, S., Mahdi, A.A. et al. Cytokine Gene Polymorphism in Idiopathic Nephrotic Syndrome Children. Ind J Clin Biochem 26, 296–302 (2011). https://doi.org/10.1007/s12291-011-0126-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12291-011-0126-2